Romvac Company S.A. is a modern research and production unit endowed with the appropiate level of scientific approach on research in microbiology, immunology and, in particular, in the preparation and control of biological products under the IMUNOINSTANT brand.
Romvac Company S.A. has:
– the IMS (Integrated Management System) certification, which includes: ISO 9001 Quality Management, ISO 14001 Environmental Management System and OHSAS 18001: 2004 Occupational Health and Safety System;
– Confirmation of compliance with Good Manufacturing Practice (GMP);
– Research activity in human and veterinary medicine (1965-present);
– the attestation for carrying out the activity of Development Research in the field of Veterinary Medicine, the unit being in the scientific coordination of the Academy of Agricultural and Forestry Sciences;
– production of bio preparations and veterinary medicines (1970-present);
– SPF egg and poultry production (1965-present).
Romvac Company S.A. and its experience in Veterinary Medicine:
– Poultry (1965-present);
– Specific pathogen free birds raising (SPF), (1965-present);
– avian pathology (Marek’s disease, avian leucosis), (1965-present);
– bovine pathology (bovine leucosis, tuberculosis), (1977-present).
Romvac Company S.A. and its experience in Human Medicine:
– Inactivated influenza vaccine for human use (1970);
– human cancer immunology (leukemia, lymphomas, sarcomas), (1971-2007);
– virological, genetic and epidemiological studies on HIV / AIDS in children from Romania (1989-2007);
– the production of Pop Popa biological valve (1984-1986);
– Comparative Pathology Research (Human and Animal) (1965-present).
Specific personalized therapy
Romvac Company S.A. holds 17 patents applied in production (1965-present)
Streptococcus group B
HPV, 9 strains
Herpes type I virus
Prevotella oralis (under authorization)
Parvimonas micra (under authorization)
Chlamydia (under authorization)